SYnAbs enters in Italy!


SynAbs is proud to announce a strategic deal with successful company DBA Italia which already distributes significant references in the field of monoclonal antibodies and will consequently extend its catalog with unique mAbs references from SYnAbs. Under the terms of the agreement, DBA Italia will have access to the unique portfolio of rats and guinea pigs mAbs to address Italian territory needs in R&D and IVD fields.